Epitomee Medical Ltd
EPIT.TA
Get informed when a big investor buys or sells
+ FollowMarket Cap$108.15M
Close$
$85.33
76.2% downside
Current Fair Value
76.2% downsideOvervalued by 76.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $108.15 Million |
|---|---|
| Enterprise Value | $100.86 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.99 |
| Beta | 0.55 |
| Outstanding Shares | 30,124,292 |
Return
| Return on Equity | -74.31% |
|---|---|
| Return on Assets | -54.69% |
| Return on Invested Capital | -58.50% |
Valuation & Multiples
| P/E Ratio | -2.28 |
|---|---|
| PEG | -1.59 |
| Price to Sales | - |
| Price to Book Ratio | 179.3 |
| Enterprise Value to Revenue | 27.55 |
| Enterprise Value to EBIT | -2.19 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Epitomee Medical Ltd
44 employees
CEO: Radan Hashimshony Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions. Epitomee ...